Top entities: OraSure Technologies, United States — Food and Drug Administration, World Health Organization, United States — Biomedical Advanced Research and Development Authority, Democratic Republic of the Congo.

What category does this event fall under?

Regulatory — classified as regulatory approval.

What is the sentiment of coverage?

Aggregate sentiment score: 40 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

United States — Food and Drug Administration granted emergency use authorization OraSure Technologies · OraSure Technologies developed test · World Health Organization declared emergency

Is this event still developing?

This is an active story, last updated Jul 21, 2026. Coverage continues to evolve.

Regulatory regulatory approval

OraSure gets EUA for Ebola 2.0 test

Q: When did this event occur?

First reported Jul 21, 2026; last updated Jul 21, 2026.

Q: What is the market impact?

General. OraSure's EUA positions it to capture significant demand during a global health emergency, potentially boosting revenues.

Analysis based on 8 articles · First reported Jul 21, 2026 · Last updated Jul 21, 2026

Sentiment

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

OraSure's EUA positions it to capture significant demand during a global health emergency, potentially boosting revenues. The stock may see positive sentiment as the company scales production of a critical diagnostic tool.

Diagnostic testing Healthcare Biotechnology

Event Summary

OraSure Technologies received Emergency Use Authorization (EUA) from the U.S. United States — Food and Drug Administration (FDA) for its second-generation OraQuick Ebola 2.0 Rapid Antigen Test. The test detects all four Ebola viruses causing human disease, including the Bundibugyo virus responsible for the current outbreak in Central Africa. The authorization comes during an Ebola epidemic centered in the Democratic Republic of the Congo with cases in Uganda, which has prompted the World Health Organization to declare a global public health emergency. OraSure is ramping up production to meet demand. The test was developed with support from the United States — Biomedical Advanced Research and Development Authority (BARDA).

Key Actions

100 United States — Food and Drug Administration granted emergency use authorization OraSure Technologies

70 OraSure Technologies developed test

60 World Health Organization declared emergency

Entities Involved

stock

OraSure Technologies

OraSure received EUA for its second-generation Ebola test, enhancing its product portfolio and market position during an outbreak.

Importance 100.0 Sentiment 70.0

govactor

United States — Food and Drug Administration

The FDA granted EUA for OraSure's test, facilitating rapid deployment during a public health emergency.

Importance 60.0 Sentiment 0.0

ngo

World Health Organization

WHO declared a global public health emergency due to the Ebola outbreak, underscoring the need for diagnostics.

Importance 50.0 Sentiment 0.0

govactor

United States — Biomedical Advanced Research and Development Authority

BARDA funded the development of the test under a 2022 contract, supporting pandemic preparedness.

Importance 40.0 Sentiment 0.0

cnt

Democratic Republic of the Congo

The DRC is the epicenter of the Ebola outbreak, with hundreds of deaths and ongoing transmission.

Importance 40.0 Sentiment -30.0

cnt

Uganda

Uganda has reported Ebola cases linked to the DRC outbreak, contributing to regional spread.

Importance 30.0 Sentiment -20.0

per

Carrie Eglinton Manner

As CEO, she announced the EUA and highlighted the test's importance during the outbreak.

Importance 30.0 Sentiment 0.0

Relationships

United States — Food and Drug Administration related ↔ World Health Organization

United States — Food and Drug Administration related ↔ United States — Biomedical Advanced Research and Development Authority

United States — Food and Drug Administration related ↔ Democratic Republic of the Congo

United States — Food and Drug Administration related ↔ Uganda

World Health Organization operator ↔ Democratic Republic of the Congo The World Health Organization operates extensively in the Democratic Republic of the Congo to coordinate international r

World Health Organization operator ↔ Uganda The World Health Organization operates a country office in Uganda, collaborating with the national government to manage

Democratic Republic of the Congo regional partner ↔ Uganda The Democratic Republic of the Congo views Uganda as a key regional partner within the East African Community, collabora

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard